Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
Joana Relat(Instituto de Salud Carlos III), Teresa Puig(IrsiCaixa)
Cited by 101
Related Papers
Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer
|Breast Cancer Research|2019|72
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
|PLoS ONE|2015|67
(−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
|Molecules|2018|45